SoftMaxx AI sells no peptides and takes no vendor money.
No supporting study We found no independent, placebo-controlled trial of Matrixyl 3000 itself. The human data are a 20-person uncontrolled study of creams with unspecified palmitoyl peptides plus other actives, and a 3-volunteer study that tracked where its two peptides sit in the skin's outer layer. A 2025 review notes a 'surprising absence of clinical studies' using pal-GHK, one of its two peptides.[1][2][3]
The tier describes the evidence for Matrixyl 3000's effect on skin aging; the studies on this page concern skin penetration, an uncontrolled multi-ingredient cream and GHK-Cu cell work.
What Matrixyl 3000 is
Matrixyl 3000 is a branded ingredient combining two fatty-acid-tagged peptides: palmitoyl tripeptide-1 (pal-GHK, the GHK sequence of copper peptide but without copper) and palmitoyl tetrapeptide-7 (pal-GQPR) [2]. A 2026 study describes the two peptides as employed to promote extracellular matrix remodelling and reduce visible signs of skin ageing [2].
Pal-GHK is the palmitoylated form of GHK; GHK-Cu is the copper form [3].
- In vitro (cells) Proposed: pal-GHK carries the GHK sequence, and the copper form, GHK-Cu, raised collagen synthesis in fibroblast cultures [4]; a 2025 review notes a surprising absence of clinical studies using GHK-Cu or pal-GHK [3]. The claim that pal-GQPR lowers the inflammatory signal IL-6 is a marketing claim we could not find tested in a peer-reviewed abstract. In three volunteers, both peptides were detected throughout the stratum corneum, with signals that the authors say suggest they sat only on the outer surfaces of its cells, not inside them [2].[4][3][2]
Claims vs. evidence
Each popular claim, graded by the strongest study behind it. The words in quotation marks are how the claim is marketed; the text after the grade is what the studies show.
- Claim as marketed
Reduces wrinkles and improves firmness
Human, small or uncontrolled Uncontrolled 20-person, 4-week study of an eye cream and a face cream with unspecified palmitoyl peptides, milk-thistle seed oil, vitamin E and other actives: crow's-feet wrinkles were 14% lower than at the start, with no comparison group, so the effect cannot be attributed to Matrixyl 3000.[1] - Claim as marketed
Stimulates collagen (pal-GHK)
In vitro (cells) (GHK-Cu data) Extrapolated from a fibroblast study of GHK-Cu, the copper form, not pal-GHK [4]. A 2025 review notes a surprising absence of clinical studies using GHK-Cu or pal-GHK [3].[4][3] - Claim as marketed
Reduces inflammation / IL-6 (pal-GQPR)
Expert review We could not find the IL-6 claim tested in a peer-reviewed abstract. A 2021 review of peptides in sensitive-skin cosmetics, palmitoyl tetrapeptide-7 among them, found their supporting data mostly in patents and supplier brochures rather than randomized placebo-controlled studies.[5] - Claim as marketed
Penetrates skin to reach the dermis
Human, small or uncontrolled In three volunteers, both peptides were detected throughout the stratum corneum, but their signals dropped immediately in depth profiling, which the authors say suggests they sat only on the outer surfaces of its cells. Only the stratum corneum was sampled; the dermis was not tested.[2]
Common myths, checked
- Common belief
Matrixyl 3000 is clinically proven to double collagen / match retinol.
Expert review We did not find these figures in a peer-reviewed study. A 2017 review notes that results for some cosmetic peptides are sparse or not published in scientific journals [6], and a 2021 review of seven peptides in sensitive-skin cosmetics, palmitoyl tetrapeptide-7 among them, found the available data mostly in patents and supplier brochures [5]. We found no independent randomized trial of Matrixyl 3000 itself.[6][5][3] - Common belief
Matrixyl 3000 is a copper peptide.
Expert review Its tripeptide, palmitoyl tripeptide-1 (pal-GHK) [2], has the GHK sequence but carries a palmitoyl group, not copper [3].[3][2] - Common belief
Peptides in serums sink deep into the dermis.
Human, small or uncontrolled In 3 volunteers, Matrixyl 3000's peptides were detected throughout the stratum corneum, apparently on the outer surfaces of its cells rather than inside them. The study sampled only that outer layer, so it says nothing about the dermis.[2]
Doses used in studies (not a recommendation)
These are the amounts given to the people, animals or cells in the cited studies, copied as reported. They are a record of what was tested, not dosing instructions, and nothing here says what you should take.
| Studied in | Route | Amount reported | How often | How long | n | Source |
|---|---|---|---|---|---|---|
| Humans | topical serum (permeation study) | serum formulation containing Matrixyl 3000 (concentration not stated in abstract) | single application | 0.5, 2 and 5 h exposure | 3 | [2] 3 healthy female volunteers |
Side effects and risks
- Human, small or uncontrolled No abnormal skin responses in an uncontrolled 20-person, 4-week study of palmitoyl-peptide creams[1]
Regulatory status (checked 2026-09-30)
- United States (FDA)We found no FDA-approved product containing Matrixyl 3000 in Drugs@FDA (searched 2026-10-01). (FDA:
Drugs@FDA search: matrixyl-3000 — no approved product found
) FDA does not approve cosmetic products or ingredients (other than color additives) before they go on the market, and a product intended to affect the structure or any function of the body is legally a drug. (FDA:Is It a Cosmetic, a Drug, or Both?
) - CanadaWe found no product containing Matrixyl 3000 in Health Canada’s Drug Product Database (searched 2026-10-01). (Health Canada:
Health Canada Drug Product Database search: matrixyl-3000 — no product found
) - Sport (WADA)WADA’s Prohibited List does not name Matrixyl 3000. WADA states that topical cosmetic products may contain prohibited peptides or growth factors and that using cosmetic products containing such substances is prohibited; we found no WADA statement on whether Matrixyl 3000 is one of them. (WADA:
World Anti-Doping Code International Standard Prohibited List 2026
; WADA:World Anti-Doping Agency Prohibited List
)
Official sources: FDA: Is It a Cosmetic, a Drug, or Both?
· WADA: World Anti-Doping Code International Standard Prohibited List 2026
· WADA: World Anti-Doping Agency Prohibited List
Report a side effect
If something went wrong after using any product, tell a clinician and report it. Reports are how regulators find contaminated or mislabeled products.
- FDA MedWatch (United States)
- Canada Vigilance Program (Canada)
Common questions
Does Matrixyl 3000 work?
We found no independent, placebo-controlled trial of Matrixyl 3000 itself. The human data are a 20-person uncontrolled study of creams with unspecified palmitoyl peptides plus other actives, and a 3-volunteer study that tracked where its two peptides sit in the skin's outer layer. A 2025 review notes a 'surprising absence of clinical studies' using pal-GHK, one of its two peptides.[1][2][3]
References
Every reference below was matched to its PubMed or DOI record (title checked) before publication. "Verified" means the paper exists and is the one named; what it supports is stated next to each claim.
Instrumental evaluation of anti-aging effects of cosmetic formulations containing palmitoyl peptides, Silybum marianum seed oil, vitamin E and other functional ingredients on aged human skin.
PubMed 27446338 DOIPermeation behaviour of cosmetic actives into the human stratum corneum.
PubMed 42790608 DOITopically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospective.
PubMed 39963574 DOIStimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+.
PubMed 3169264 DOIUsage of Synthetic Peptides in Cosmetics for Sensitive Skin.
PubMed 34451799 DOITopical Peptide Treatments with Effective Anti-Aging Results
DOI
Keep reading
- Best peptides for skin, ranked by evidence→
- Copper peptides vs retinol: what the evidence shows→
- Peptides for looksmaxxing: what the evidence actually shows→
- GHK-Cu (copper tripeptide-1): what the evidence shows→
- Argireline (acetyl hexapeptide-8): what the evidence shows→
- Matrixyl (palmitoyl pentapeptide-4, pal-KTTKS): what the evidence shows→
- All peptide pages, by evidence→